Literature DB >> 16170519

[Y402H polymorphism in complement factor H and age-related macula degeneration (AMD)].

H P N Scholl1, B H F Weber, M M Nöthen, T Wienker, F G Holz.   

Abstract

Age-related macular degeneration is a complex genetic disorder. Recent data suggest that the additive genetic risk for late-stage disease is more than two-thirds. Comprehensive genetic studies (candidate gene approaches, linkage and association studies) have been performed in recent years to identity the genetic risk factors at the molecular lavel. Very recently, a significant risk allele, Y402H, has been discovered in the complement factor H (CFH) gene. The relative risk of developing AMD has been estimated between 2.4-4.6 for heterozygotes and 3.3-7.4 for homozygotes. This polymorphism accounts for approximately 20-50% of the overall risk of developing AMD. In this review the results from molecular genetic studies in AMD are summarized, with a special emphasis on the recent data obtained for the CFH gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170519     DOI: 10.1007/s00347-005-1270-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  61 in total

1.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

Authors:  Daniel E Weeks; Yvette P Conley; Hui-Ju Tsai; Tammy S Mah; Silke Schmidt; Eric A Postel; Anita Agarwal; Jonathan L Haines; Margaret A Pericak-Vance; Philip J Rosenfeld; T Otis Paul; Andrew W Eller; Lawrence S Morse; J P Dailey; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2004-05-27       Impact factor: 11.025

2.  Evaluation of the ELOVL4 gene in patients with age-related macular degeneration.

Authors:  R Ayyagari; K Zhang; A Hutchinson; Z Yu; A Swaroop; L E Kakuk; J M Seddon; P S Bernstein; R A Lewis; J Tammur; Z Yang; Y Li; H Zhang; B M Yashar; J Liu; K Petrukhin; P A Sieving; R Allikmets
Journal:  Ophthalmic Genet       Date:  2001-12       Impact factor: 1.803

3.  Genetic risk of age-related maculopathy. Population-based familial aggregation study.

Authors:  C C Klaver; R C Wolfs; J J Assink; C M van Duijn; A Hofman; P T de Jong
Journal:  Arch Ophthalmol       Date:  1998-12

4.  The grading and prevalence of macular degeneration in Chesapeake Bay watermen.

Authors:  N M Bressler; S B Bressler; S K West; S L Fine; H R Taylor
Journal:  Arch Ophthalmol       Date:  1989-06

5.  Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; K L Linton
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy.

Authors:  Yvette P Conley; Anbupalam Thalamuthu; Johanna Jakobsdottir; Daniel E Weeks; Tammy Mah; Robert E Ferrell; Michael B Gorin
Journal:  Hum Mol Genet       Date:  2005-06-01       Impact factor: 6.150

8.  Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.

Authors:  U Felbor; D Doepner; U Schneider; E Zrenner; B H Weber
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-05       Impact factor: 4.799

Review 9.  Genetic susceptibility to age related macular degeneration.

Authors:  J R Yates; A T Moore
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

10.  Microarray analysis of gene expression in the aging human retina.

Authors:  Shigeo Yoshida; Beverly M Yashar; Suja Hiriyanna; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

View more
  9 in total

Review 1.  [Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options].

Authors:  A Lommatzsch
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

2.  [Reticular drusen over time with SD-OCT].

Authors:  J Auge; J S Steinberg; M Fleckenstein; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

Review 3.  [Intravitreal bevacizumab for neovascular age-related macular degeneration].

Authors:  M S Ladewig; F Ziemssen; G Jaissle; H-M Helb; H P N Scholl; N Eter; K U Bartz-Schmidt; F G Holz
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

Review 4.  RPE necroptosis in response to oxidative stress and in AMD.

Authors:  Jakub Hanus; Chastain Anderson; Shusheng Wang
Journal:  Ageing Res Rev       Date:  2015-09-11       Impact factor: 10.895

Review 5.  Complement Mediators in Development to Treat Age-Related Macular Degeneration.

Authors:  Marcella Nebbioso; Federica Franzone; Alessandro Lambiase; Samanta Taurone; Marco Artico; Magda Gharbiya; Antonio Greco; Antonella Polimeni
Journal:  Drugs Aging       Date:  2022-01-20       Impact factor: 3.923

6.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  K A Schlauch; S F Khaiboullina; K L De Meirleir; S Rawat; J Petereit; A A Rizvanov; N Blatt; T Mijatovic; D Kulick; A Palotás; V C Lombardi
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

Review 7.  Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.

Authors:  Majda Hadziahmetovic; Goldis Malek
Journal:  Front Cell Dev Biol       Date:  2021-01-25

Review 8.  Complement System and Potential Therapeutics in Age-Related Macular Degeneration.

Authors:  Young Gun Park; Yong Soo Park; In-Beom Kim
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.

Authors:  Aldacilene Souza Silva; Anderson Gustavo Teixeira; Lorena Bavia; Fabio Lin; Roberta Velletri; Rubens Belfort; Lourdes Isaac
Journal:  Mol Vis       Date:  2012-08-30       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.